NCT01295944 2025-08-05Carboplatin and Bevacizumab for Recurrent EpendymomaNational Institutes of Health Clinical Center (CC)Phase 2 Completed35 enrolled 17 charts
NCT00004645 2005-06-24Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous MethylprednisoloneOffice of Rare Diseases (ORD)Phase 3 Unknown22 enrolled